TY - JOUR
T1 - Physiotherapy improves motor function in patients with the Parkinson variant of multiple system atrophy
T2 - A prospective trial
AU - Raccagni, C.
AU - Goebel, G.
AU - Gaßner, H.
AU - Granata, Roberta
AU - Ndayisaba, Jean Pierre
AU - Seebacher, Barbara
AU - Schoenherr, Gudrun
AU - Mitterhuber, Jakob
AU - Hendriks, Pascalle
AU - Kaindlstorfer, Christine
AU - Eschlboeck, Sabine
AU - Fanciulli, Alessandra
AU - Krismer, Florian
AU - Seppi, Klaus
AU - Poewe, Werner
AU - Bloem, Bastiaan R.
AU - Klucken, J.
AU - Wenning, Gregor K.
N1 - Funding Information:
Heiko Ga?ner reports institutional research grants from the Bavarian Ministry of Economic Affairs and Media, Energy and Technology (Medical Valley Award, Fall-Risk-PD), and MoveIT, an EIT Health innovation project.Florian Krismer reports one research grant from MSA coalition, a travel grant from Austrian Parkinson Society (??PG?), Congress registration waiver from the International Parkinson's disease and Movement Disorders Society.Klaus Seppi: reports personal fees from Teva, UCB, Lundbeck, AOP Orphan Pharmaceuticals AG, Roche, Gr?nenthal and Abbvie, honoraria from the International Parkinson and Movement Disorders Society, research grants from FWF Austrian Science Fund, Michael J. Fox Foundation, and International Parkinson and Movement Disorder Society, outside the submitted work.Bastiaan R. Bloem: serves as an associate Editor for the Journal of Parkinson's disease, serves on the editorial of Practical Neurology and Digital Biomarkers, has received honoraria from serving on the scientific advisory board for Abbvie, Biogen, UCB and Walk with Path, has received fees for speaking at conferences from AbbVie, Zambon and Bial, and has received research support from the Netherlands Organization for Scientific Research, the Michael J Fox Foundation, UCB, Abbvie, the Stichting Parkinson Fonds, the Hersenstichting Nederland, the Parkinson's Foundation, Verily Life Sciences, Horizon 2020, the Topsector Life Sciences and Health, and the Parkinson Vereniging. He has received grants from Netherlands Organization for Scientific Research, Stichting Parkinson Fonds, Michael J Fox Foundation, Parkinson Vereniging, Parkinson's Foundation, Hersenstichting Nederland, Verily Life Sciences, Horizon 2020, Topsector Life Sciences and Health, UCB, Abbvie.Jochen Klucken reports institutional research grants from EIT-Health; EIT-Digital; EU (H2020), German Research Foundation (DFG). Industry sponsored institutional IITs and grants from Alpha-Telemed AG. Compensation and honoraria from serving on scientific advisory boards and lecturing from Ever Neuro Pharma GmbH, TEVA Pharma GmbH, Bial Deutschland GmbH; Celgene GmbH, and Magisan GmbH.Gregor K. Wenning: reports personal fees from Biohaven, Theravance, UCB, Lundbeck, and Ono, honoraria from Austrian Autonomic Society, research grants from FWF Austrian Science Fund, International Parkinson and Movement Disorder Society, and US MSA Coalition.We thank our patients and families and the MSA Coalition for supporting this research.
Funding Information:
Jochen Klucken reports institutional research grants from EIT-Health ; EIT-Digital ; EU (H2020) , German Research Foundation (DFG) . Industry sponsored institutional IITs and grants from Alpha-Telemed AG. Compensation and honoraria from serving on scientific advisory boards and lecturing from Ever Neuro Pharma GmbH, TEVA Pharma GmbH, Bial Deutschland GmbH; Celgene GmbH, and Magisan GmbH.
Funding Information:
Gregor K. Wenning: reports personal fees from Biohaven, Theravance, UCB, Lundbeck, and Ono, honoraria from Austrian Autonomic Society, research grants from FWF Austrian Science Fund , International Parkinson and Movement Disorder Society , and US MSA Coalition .
Funding Information:
Bastiaan R. Bloem: serves as an associate Editor for the Journal of Parkinson's disease, serves on the editorial of Practical Neurology and Digital Biomarkers, has received honoraria from serving on the scientific advisory board for Abbvie, Biogen, UCB and Walk with Path, has received fees for speaking at conferences from AbbVie, Zambon and Bial, and has received research support from the Netherlands Organization for Scientific Research , the Michael J Fox Foundation , UCB , Abbvie , the Stichting Parkinson Fonds , the Hersenstichting Nederland , the Parkinson's Foundation , Verily Life Sciences , Horizon 2020 , the Topsector Life Sciences and Health , and the Parkinson Vereniging . He has received grants from Netherlands Organization for Scientific Research , Stichting Parkinson Fonds , Michael J Fox Foundation , Parkinson Vereniging , Parkinson's Foundation , Hersenstichting Nederland , Verily Life Sciences , Horizon 2020 , Topsector Life Sciences and Health , UCB , Abbvie .
Publisher Copyright:
© 2019 Elsevier Ltd
PY - 2019/10
Y1 - 2019/10
N2 - Background and objectives: Gait impairment and reduced mobility are disabling symptoms of multiple system atrophy. While physiotherapy is increasingly recognized as a valuable supplement to pharmacotherapy for patients with Parkinson's disease, data on the efficacy of physiotherapy for multiple system atrophy are lacking. This study aimed to explore the feasibility of two consecutive exercise-based interventions in patients with multiple system atrophy. Subjects and Methods: We included 10 patients with the parkinsonian variant of multiple system atrophy and 10 patients with Parkinson's disease, matched for gender and Hoehn & Yahr stage (≤3). Interventions consisted of a five-day inpatient physiotherapy program followed by a five-week unsupervised home-based exercise program. Outcomes included instrumented gait analysis, patient questionnaires, clinical rating scales and physical tests. Patients were examined at baseline, after the first inpatient treatment and again after the home-based intervention. Additionally, a structured telephone interview was performed immediately after the second intervention period. Results: Both patient groups exhibited a similar improvement of gait after the interventions, as measured by instrumented gait analysis. These effects reached their maximum level after inpatient physiotherapy and remained stable following the home-based exercise program. Patient questionnaires also showed improvements after the interventions, but motor clinical rating scales did not. Conclusion: Our pilot results suggest that a short-term bout of physiotherapy is feasible, safe and improves gait performance in patients with multiple system atrophy. This highlights the potential of physiotherapy for this disabling condition where pharmacotherapy typically achieves poor effects. The present findings warrant a larger controlled study.
AB - Background and objectives: Gait impairment and reduced mobility are disabling symptoms of multiple system atrophy. While physiotherapy is increasingly recognized as a valuable supplement to pharmacotherapy for patients with Parkinson's disease, data on the efficacy of physiotherapy for multiple system atrophy are lacking. This study aimed to explore the feasibility of two consecutive exercise-based interventions in patients with multiple system atrophy. Subjects and Methods: We included 10 patients with the parkinsonian variant of multiple system atrophy and 10 patients with Parkinson's disease, matched for gender and Hoehn & Yahr stage (≤3). Interventions consisted of a five-day inpatient physiotherapy program followed by a five-week unsupervised home-based exercise program. Outcomes included instrumented gait analysis, patient questionnaires, clinical rating scales and physical tests. Patients were examined at baseline, after the first inpatient treatment and again after the home-based intervention. Additionally, a structured telephone interview was performed immediately after the second intervention period. Results: Both patient groups exhibited a similar improvement of gait after the interventions, as measured by instrumented gait analysis. These effects reached their maximum level after inpatient physiotherapy and remained stable following the home-based exercise program. Patient questionnaires also showed improvements after the interventions, but motor clinical rating scales did not. Conclusion: Our pilot results suggest that a short-term bout of physiotherapy is feasible, safe and improves gait performance in patients with multiple system atrophy. This highlights the potential of physiotherapy for this disabling condition where pharmacotherapy typically achieves poor effects. The present findings warrant a larger controlled study.
KW - Atypical parkinsonian disorders
KW - Home-based training
KW - Multiple system atrophy
KW - Parkinson's disease
KW - Physiotherapy
UR - http://www.scopus.com/inward/record.url?scp=85072612315&partnerID=8YFLogxK
U2 - 10.1016/j.parkreldis.2019.09.026
DO - 10.1016/j.parkreldis.2019.09.026
M3 - Article
C2 - 31621609
AN - SCOPUS:85072612315
VL - 67
SP - 60
EP - 65
JO - Parkinsonism and Related Disorders
JF - Parkinsonism and Related Disorders
SN - 1353-8020
ER -